Collaboration between rheumatologists and oncologists is needed to detect and manage autoimmune rheumatic conditions that may be triggered by immunotherapy drugs, researchers say. French clinicians have reported a series of 10 patients who developed rheumatoid arthritis or polymyalgia rheumatica (PMR) after treatment with immune checkpoint inhibitors (ICI) for a range of cancers. They found rheumatoid arthritis ...
Do cancer immunotherapy treatments trigger RA?
By Mardi Chapman
28 Mar 2018